Monoclonal Anti-Human parainfluenza viruses Pre-fusion glycoprotein F0 Antibody, Human IgG1 (15A10) (MALS verified)

用户评价
货号-规格
价格
Qty.
HPV-MY2325-100ug
¥3500.00
HPV-MY2325-1mg (500ug X 2)
¥23100.00
合计0件 产品金额¥ 0

产品详情

  • 抗体来源(Source)

    Monoclonal Anti-Human parainfluenza viruses Pre-fusion glycoprotein F0 Antibody, Human IgG1 (15A10) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.

  • 克隆号(Clone)

    15A10

  • 种属(Species)

    Mouse

  • 亚型(Isotype)

    Human IgG1 | Human Kappa

  • 偶联(Conjugate)

    Unconjugated

  • 抗体类型(Antibody Type)

    Recombinant Monoclonal

  • 种属反应性(Reactivity)

    Virus

  • 免疫原(Immunogen)

    Recombinant Human parainfluenza viruses Pre-fusion glycoprotein F0 is expressed from human 293 cells

  • 特异性(Specificity)

    Specifically recognizes Human parainfluenza viruses Pre-fusion glycoprotein F0.

  • 应用(Application)

    Application
    Recommended Usage
    Western Blot
    10-0.1 μg/mL
    ELISA
    0.04-20 ng/mL
  • 纯度(Purity)

    95% as determined by SDS-PAGE.

    90% as determined by SEC-MALS.

  • 纯化(Purification)

    Protein A purified / Protein G purified

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 电泳(SDS-PAGE)

    Human parainfluenza viruses SDS-PAGE

    Monoclonal Anti-Human parainfluenza viruses Pre-fusion glycoprotein F0 Antibody, Human IgG1 (15A10) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Human parainfluenza viruses SEC-MALS

    The purity of Monoclonal Anti-Human parainfluenza viruses Pre-fusion glycoprotein F0 Antibody, Human IgG1 (15A10) (Cat. No. HPV-MY2325) is more than 90% and the molecular weight of this protein is around 135-165 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-ELISA

     Human parainfluenza viruses ELISA

    Immobilized Human parainfluenza viruses Pre-fusion glycoprotein F0, His Tag (Cat. No. PR0-H52H3) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human parainfluenza viruses Pre-fusion glycoprotein F0 Antibody, Human IgG1 (15A10) (Cat. No. HPV-MY2325) with a linear range of 0.04-2 ng/mL (QC tested).

    Protocol
  • Western Blot验证

     Human parainfluenza viruses WESTERN BLOT
  • Detection of Monoclonal Anti-Human parainfluenza viruses Pre-fusion glycoprotein F0 Antibody, Human IgG1 (15A10) (MALS verified) by Western Blot. Monoclonal Anti-Human parainfluenza viruses Pre-fusion glycoprotein F0 Antibody, Human IgG1 (15A10) (MALS verified) at 0.10 μg/mL dilution + Human parainfluenza viruses Pre-fusion glycoprotein F0, His Tag (MALS verified) at 400 ng.

    Secondary: (HFC)-Peroxidase AffiniPure Goat Anti-Human IgG, Fcγ fragment specific at 1/2000 dilution.

    Predicted band size: 65 kDa 12% Bis-Tris Protein Gel

用户评价
发表评论

背景介绍

Anti-Human Parainfluenza Viruses Antibody, is a monoclonal antibody designed to specifically recognize antigens from human parainfluenza viruses (HPIVs), a group of enveloped, negative-sense RNA viruses that cause acute respiratory tract infections. HPIVs are a major cause of illness in infants, young children, the elderly, and immunocompromised individuals. This antibody is commonly used in research and diagnostic applications, including ELISA, immunofluorescence, and neutralization assays, to detect viral proteins, study infection mechanisms, and support vaccine or therapeutic development.

前沿进展

 
联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价
  • 背景介绍